Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000007

CFO AND TREASURER sold 21,000 shares at an average $473.64 ($9,946,544)

  • CFO AND TREASURER acquired 21,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

16 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-24 Exercise or conversion : show line 1 in the form 10b5-1 +21,000 $146.03 $3,066,630 29,142 D
2025-11-24 Sale : show line 2 in the form 10b5-1 −960 $467.35 $448,658 28,182 D
2025-11-24 Sale : show line 3 in the form 10b5-1 −1,850 $468.29 $866,330 26,332 D
2025-11-24 Sale : show line 4 in the form 10b5-1 −1,552 $469.34 $728,414 24,780 D
2025-11-24 Sale : show line 5 in the form 10b5-1 −2,919 $470.22 $1,372,575 21,861 D
2025-11-24 Sale : show line 6 in the form 10b5-1 −1,971 $471.88 $930,076 19,890 D
2025-11-24 Sale : show line 7 in the form 10b5-1 −1,788 $472.73 $845,233 18,102 D
2025-11-24 Sale : show line 8 in the form 10b5-1 −280 $473.54 $132,592 17,822 D
Open-market sales · 21,000 sh · avg $473.64 · $9,946,544

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-11-24 Exercise or conversion : show line 17 in the form 10b5-1 Stock Option −21,000 $146.03 2027-03-15 21,000 517 D
Loading xslF345X05/primarydocument.xml…